Stay updated on Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial
Sign up to get notified when there's something new on the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page.

Latest updates to the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page
- Check2 days agoChange DetectedA new revision tag `v3.5.4` was added, replacing the previous `v3.5.3`. This indicates the page's revision history has advanced to a newer release.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page’s footer/app revision indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a backend/interface version change rather than any change to the study record.SummaryDifference0.1%

- Check31 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No user-facing content or functionality appears to change.SummaryDifference0.1%

- Check45 days agoChange DetectedGaucher disease type I has been added as a related condition term on the study page.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision: v3.4.3 was added, replacing the previous v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page.